Valuation: Adocia

Market Cap 40.42M 45.24M 37.71M 34.26M 64.52M 4.38B 65M 453M 177M 2.23B 170M 166M 7.16B P/E 2026 *
4.62x
P/E 2027 * 2.99x
Enterprise Value -8.34M -9.34M -7.78M -7.07M -13.31M -903M -13.41M -93.53M -36.54M -459M -35.05M -34.29M -1.48B EV / Sales 2026 *
-0.54x
EV / Sales 2027 * 1.88x
Free-Float
93.92%
Yield 2026 *
-
Yield 2027 * -
1 day-1.62%
1 week-16.36%
Current month-16.36%
1 month-47.78%
3 months-47.96%
6 months-52.68%
Current year-69.16%
1 week 2.05
Extreme 2.05
2.3
1 month 2.05
Extreme 2.05
3.96
Current year 2.05
Extreme 2.05
7.45
1 year 2.05
Extreme 2.05
12.4
3 years 2.05
Extreme 2.05
12.66
5 years 2.05
Extreme 2.05
16.16
10 years 2.05
Extreme 2.05
61.9
Manager TitleAgeSince
Chief Executive Officer 55 2023-05-10
Director of Finance/CFO - 2024-09-22
Chief Tech/Sci/R&D Officer - 2014-11-30
Director TitleAgeSince
Director/Board Member 55 2013-04-18
Chairman 57 -
Director/Board Member 61 2023-05-10
Date Insider Type Main position Quantity % Market Cap. Importance
2/27/25 Buy

Founder

109,170 0.6972%
4/6/24 Buy

Founder

15,576 0.1105%
4/6/24 Buy

Founder

51,921 0.3685%
Change 5-day change 1-year change 3-year change Capi.($)
-1.62%-16.36%-73.68%-72.45% 46.29M
+4.16%+4.16%+49.37%+94.17% 74.69B
+0.46%-0.97%+23.51%+79.34% 58.81B
+0.17%+0.35%+6.85%+34.55% 48.45B
+0.50%-2.14%+331.33%+702.20% 42.84B
-0.72%-3.99%+28.50%+29.94% 42.79B
+0.34%-0.52%+6.56%+109.35% 41.25B
-0.11%+1.96%+9.19%+52.66% 31.13B
-0.50%-3.10%-10.19%-14.35% 24.05B
-3.32%-10.86%-37.32%+316.28% 22.98B
Average -0.06%-3.77%+33.41%+133.17% 38.7B
Weighted average by Cap. +0.67%-1.80%+52.36%+149.36%

Financials

2026 *2027 *
Net sales 15.45M 17.3M 14.42M 13.1M 24.67M 1.67B 24.85M 173M 67.69M 851M 64.93M 63.53M 2.74B 37.6M 42.08M 35.08M 31.86M 60.01M 4.07B 60.46M 422M 165M 2.07B 158M 155M 6.66B
Net income 332K 371K 309K 281K 529K 35.89M 533K 3.72M 1.45M 18.25M 1.39M 1.36M 58.68M -44.33M -49.61M -41.36M -37.56M -70.75M -4.8B -71.28M -497M -194M -2.44B -186M -182M -7.85B
Net Debt -48.77M -54.58M -45.5M -41.33M -77.83M -5.28B -78.41M -547M -214M -2.69B -205M -200M -8.63B 30.18M 33.77M 28.15M 25.57M 48.16M 3.27B 48.52M 338M 132M 1.66B 127M 124M 5.34B
Projected Income Statement - Annual - Adocia
Logo Adocia
Adocia is a biotechnology company specializing in the discovery and development of therapeutic solutions in the field of metabolic diseases, primarily diabetes and obesity. The Company has a broad portfolio of drug candidates based on four proprietary technology platforms : BioChaperone® for the stabilization and enhancement of peptide formulations and combinations, AdoXLongTM, a long-acting peptide platform, AdOral®, an oral peptide delivery technology, and AdoShell®, an immunoprotective biomaterial for cell transplantation, with an initial application in pancreatic cells transplantation.
Employees
73
Date Price Change Volume
26-10-07 €2.066 -1.62% 99,663
26-10-06 €2.100 -1.41% 113,144
26-10-05 €2.130 -0.75% 139,889
26-10-02 €2.146 -4.62% 298,083
26-10-01 €2.250 -8.91% 476,037
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Ratings Surperformance© - Adocia
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.066EUR
Average target price
9.700EUR
Spread / Average Target
+369.51%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Adocia
  1. Stock Market
  2. Stocks
  3. ADOC Stock